GILEAD SCIENCES SL
- Country
- ๐ช๐ธSpain
- Ownership
- -
- Established
- 1994-01-01
- Employees
- -
- Market Cap
- $95.8B
A Phase I/II Study of the Safety, Tolerance, and Pharmacokinetics of 9-(2-Phosphonylmethoxyethyl)Adenine ( PMEA; Adefovir ) in Patients With Advanced HIV Disease.
- Conditions
- First Posted Date
- 2001-08-31
- Last Posted Date
- 2005-06-24
- Lead Sponsor
- Gilead Sciences
- Target Recruit Count
- 20
- Registration Number
- NCT00002115
- Locations
- ๐บ๐ธ
Univ of Washington, Seattle, Washington, United States
Safety and Effectiveness of Adding PMPA Prodrug to an Anti-HIV Drug Combination to Treat HIV-Infected Patients
- Conditions
- First Posted Date
- 2001-08-31
- Last Posted Date
- 2005-06-24
- Lead Sponsor
- Gilead Sciences
- Target Recruit Count
- 175
- Registration Number
- NCT00002415
- Locations
- ๐บ๐ธ
Harbor UCLA Med Ctr, Torrance, California, United States
๐บ๐ธHershey Med Ctr, Hershey, Pennsylvania, United States
๐บ๐ธSan Francisco Veterans Adm Med Cntr, San Francisco, California, United States
Tenofovir Disoproxil Fumarate (TDF) in HIV-1 Patients Who Have Never Taken Anti-HIV Drugs
- Conditions
- First Posted Date
- 2001-08-31
- Last Posted Date
- 2005-06-24
- Lead Sponsor
- Gilead Sciences
- Registration Number
- NCT00016588
- Locations
- ๐บ๐ธ
Aaron Diamond AIDS Rsch Ctr / Rockefeller Univ, New York, New York, United States
A Multi-Center, Randomized, Double-Blind, Placebo-Controlled Study of the Efficacy and Safety of Adefovir Dipivoxil When Added to Standard Antiretroviral Therapy for the Treatment of HIV-Infected Patients With CD4 Cell Counts >= 200/mm3
- Conditions
- First Posted Date
- 2001-08-31
- Last Posted Date
- 2005-06-24
- Lead Sponsor
- Gilead Sciences
- Target Recruit Count
- 400
- Registration Number
- NCT00002161
- Locations
- ๐บ๐ธ
AIDS Research Consortium of Atlanta, Atlanta, Georgia, United States
๐บ๐ธEast Bay AIDS Ctr, Berkeley, California, United States
๐บ๐ธChicago Ctr for Clinical Research, Chicago, Illinois, United States
Safety and Effectiveness of Giving Adefovir (Preveon) Plus Other Anti-HIV Drugs to HIV-Infected Patients Who Have Not Responded to Other Anti-HIV Drug Combinations
- Conditions
- First Posted Date
- 2001-08-31
- Last Posted Date
- 2005-06-24
- Lead Sponsor
- Gilead Sciences
- Registration Number
- NCT00002398
- Locations
- ๐บ๐ธ
Gilead Sciences Inc, Foster City, California, United States
Phase I Study of the Safety, Tolerance, and Pharmacokinetics of 9-[2-(Bispivaloyloxymethyl)Phosphonylmethoxyethyl]Adenine (Bis-POM PMEA; Adefovir Dipivoxil) in HIV-Infected Patients
- Conditions
- First Posted Date
- 2001-08-31
- Last Posted Date
- 2005-06-24
- Lead Sponsor
- Gilead Sciences
- Target Recruit Count
- 15
- Registration Number
- NCT00002128
- Locations
- ๐บ๐ธ
Johns Hopkins Univ, Baltimore, Maryland, United States
A Compassionate Use Study of Tenofovir Disoproxil Fumarate as Treatment for HIV Infection
- Conditions
- First Posted Date
- 2001-08-31
- Last Posted Date
- 2005-06-24
- Lead Sponsor
- Gilead Sciences
- Target Recruit Count
- 300
- Registration Number
- NCT00002453
- Locations
- ๐บ๐ธ
Tenofovir Coordinating Center, Foster City, California, United States
Tenofovir Disoproxil Fumarate in HIV-Infected Patients Who Have Not Had Success With Other Anti-HIV Drug Combinations
- Conditions
- First Posted Date
- 2001-08-31
- Last Posted Date
- 2005-06-24
- Lead Sponsor
- Gilead Sciences
- Registration Number
- NCT00011089
- Locations
- ๐บ๐ธ
Medical Information, Foster City, California, United States
The Safety and Effectiveness of Zidovudine Plus Adefovir in HIV-Infected Patients
- Conditions
- First Posted Date
- 2001-08-31
- Last Posted Date
- 2005-06-24
- Lead Sponsor
- Gilead Sciences
- Target Recruit Count
- 20
- Registration Number
- NCT00002326
- Locations
- ๐บ๐ธ
Natl Cancer Institute, Bethesda, Maryland, United States
A Study on the Safety and Effectiveness of Adefovir Dipivoxil in Combination With Anti-HIV Therapy (HAART) in HIV-Positive Patients
- Conditions
- First Posted Date
- 2001-08-31
- Last Posted Date
- 2005-06-24
- Lead Sponsor
- Gilead Sciences
- Target Recruit Count
- 390
- Registration Number
- NCT00002426
- Locations
- ๐บ๐ธ
Health Positive, Safety Harbor, Florida, United States
๐บ๐ธRush Presbyterian - Saint Luke's Med Ctr, Chicago, Illinois, United States
๐บ๐ธThomas Street Clinic, Houston, Texas, United States